Jeffrey buys CNC 79.63: UPDATE: Sterne Agee Initiates Coverage On Centene As Premium Performance Deserves Premium Multiple
In a report published Friday, Sterne Agee analyst Brian Wright initiated coverage on Centene (NYSE: CNC) with a Buy rating and $87.00 price target. In the report, Sterne Agee noted, âCentene has become the premier Medicaid pure-play and deserving of its ... ...
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home